ACVRL1 and acute myeloid leukemia: The binding of HHT to NKRF disrupts the translocation of p65 and its binding to the MYC promoter, resulting in the downregulation of MYC transcriptional expression, subsequently suppressing the growth of t (7, 20) acute myeloid leukemia (AML) cells (26).